Compare AZZ & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZZ | MIR |
|---|---|---|
| Founded | 1956 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Industrial Specialties | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.6B |
| IPO Year | 1994 | N/A |
| Metric | AZZ | MIR |
|---|---|---|
| Price | $119.28 | $18.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $126.00 | $27.63 |
| AVG Volume (30 Days) | 152.6K | ★ 3.3M |
| Earning Date | 04-20-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.97 | N/A |
| Revenue | ★ $1,061,817,000.00 | N/A |
| Revenue This Year | $5.53 | $24.05 |
| Revenue Next Year | $5.83 | $7.40 |
| P/E Ratio | ★ $12.19 | $195.00 |
| Revenue Growth | ★ 14.53 | N/A |
| 52 Week Low | $70.90 | $12.00 |
| 52 Week High | $141.18 | $30.28 |
| Indicator | AZZ | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 32.17 | 33.73 |
| Support Level | $107.27 | N/A |
| Resistance Level | $119.95 | $22.23 |
| Average True Range (ATR) | 4.05 | 1.04 |
| MACD | -1.24 | -0.13 |
| Stochastic Oscillator | 3.20 | 0.00 |
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.